Enhancer ID: | E_01_0203 |
Species: | human |
Position : | chr16:28929347-28931347 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Septicemia |
Pubmed ID: | 31644352 |
Enhancer experiment: | PCR, flow cytometry, immunofluorescence staining |
Enhancer experiment description: | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
Target gene : | CD19(B4,CVID3) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
TF name : | -- |
TF experiment: | PCR,Flow cytometry,?????? |
TF experiment description: | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
Enhancer function : | Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Wounds were digested as described above. Single cell suspen_x0002_sions were incubated with fluorescein isothiocyanatelabeled anti-CD3, anti-CD19, and anti-Ly6G (BioLegend) followed by antifluorescein isothiocyanate microbeads (Miltenyi Biotec). |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|